EGFR and neoplasm: A selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that inhibits tumor cell growth and increases apoptosis in tumor cell-derived lines. It can improve the antitumor activity of chemotherapy, radiotherapy and hormone therapy, and is a small molecule targeted drug for systemic targeted therapy of tumors